Home / Pharmacology / Central Nervous System

Tricyclic Antidepressant (TCA) Overdose: Biochemical Pathways (Emergency Room Synopsis)

Central Nervous System Specialty Division
â–  LECTURE OVERVIEW: Tricyclic Antidepressant (TCA) overdose is a major toxicological emergency characterized by multi-system receptors blockade. â–  THE CARDIOVASCULAR AND CENTRAL TOXICITIES: 1. Rapid Cardiac Sodium Channel Inactivation: TCAs block fast sodium channels (IKr) in myocardial tissue, slowing Phase 0 of the action potential and prolonging the QRS interval. This drives severe intraventricular conduction delays and lethal ventricular arrhythmias. 2. Anticholinergic Overdrive: Blocks muscarinic (M1) receptors, producing central and peripheral anticholinergic syndrome (altered mental status, dry skin, dilated non-reactive pupils, urinary retention, and hyperthermia). 3. Vascular Collapse: Inhibits alpha-1 adrenergic receptors, preventing peripheral vasoconstriction and causing refractory hypotension. 4. Neuronal Excitability: Blocks GABA-A receptors in the brain, lowering the seizure threshold and precipitating status epilepticus. â–  BIOCHEMICAL MECHANISMS: At the molecular level, enzyme kinetics govern reaction rates. Competitive inhibitors raise apparent Michaelis constants without changing maximum speed, whereas noncompetitive inhibitors decrease maximum speed directly. â–  EMERGENCY DECREES & FAST-TRACK RESPONSES: Upon presentation with extreme physiological disruption, initiate immediate volume restoration and broad-spectrum metabolic stabilization. [HY-BOARD-1250]

🌟 Dynamic Clinical Key:

First-line, life-saving treatment is intravenous Sodium Bicarbonate (NaHCO3). The sodium load increases extracellular sodium concentration to overcome the TCA-mediated blockade, while the systemic alkalorization (raising pH to 7.45-7.55) converts the TCA molecule into its neutral, non-ionized form, reducing its affinity for sodium channels. Focus on rate-limiting regulatory steps for pharmacological design. Confirm central vital markers continually rather than relying solely on peripheral readings.

Professional Medical Reference Application v2.5

For training, board examinations (USMLE, PLAB), and clinician benchmarking. Do not replace professional care.